Prevention and treatment of catheter-associated urinary tract infections.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D001437:Bacteriuria / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D002408:Catheters, Indwelling / Q000009:adverse effects; D003428:Cross Infection / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D008709:Methenamine / Q000627:therapeutic use; D009268:Nalidixic Acid / Q000627:therapeutic use; D009582:Nitrofurantoin / Q000627:therapeutic use; D014546:Urinary Catheterization / Q000009:adverse effects* / Q000379:methods; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control
D000900:Anti-Bacterial Agents; D009268:Nalidixic Acid; D009582:Nitrofurantoin; D008709:Methenamine